Literature DB >> 25114622

Inpatient silver sulphadiazine versus outpatient nanocrystalline silver models of care for pediatric scald burns: A value analysis.

Claudia Malic1, Cynthia Verchere1, Jugpal S Arneja1.   

Abstract

BACKGROUND/
OBJECTIVE: Scalds represent the most frequent pediatric burn injury. Inpatient nonsurgical wound management of small or medium-size burns (<20% total body surface area) represents a significant proportion of the cost of care, with nanocrystalline silver (NCS) and silver sulphadiazine (SSD) among the most commonly used dressings. Although several articles have described healing outcomes using these dressings, there are few concurrent economic analyses. To analyze overall health care value (outcomes/cost) in burns not requiring surgery, the authors compared management of scald burns with NCS versus SSD from both a quality perspective and using bottom-up microcosting to determine which dressing option optimizes health care value.
METHODS: A value analysis was performed. Published studies investigating NCS and/or SSD in the treatment of pediatric burns over the past 25 years were analyzed. Healing time, hospital duration and frequency of dressings were chosen as quality metrics. A bottom-up microcosting analysis was performed to estimate costs associated with the two dressing options.
RESULTS: Over the 25-year period, 356 studies investigated the use of SSD in burns, while 55 studies evaluated the use of NCS. Mean age and burn size were equivalent. Mean time to healing was 14.9 days for NCS and 17.2 days for SSD. The mean duration of hospital stay was 14.9 days for SSD and 5.9 days for NCS. Dressings were performed twice per week for NCS, and once or twice per day for SSD. The mean total cost per patient to the health care system was estimated to be $61,140 for SSD and $17,220 for NCS.
CONCLUSION: Published outcomes of healing time are equivalent or slightly better using NCS over SSD for pediatric scalds. The financial model illustrated a potential significant cost saving with NCS, primarily as a result of an outpatient model of care. Overall health care value is optimized using NCS for pediatric scalds.

Entities:  

Keywords:  Burn; Dressings; Microcosting; Pediatric; Scald; Value

Year:  2014        PMID: 25114622      PMCID: PMC4116324     

Source DB:  PubMed          Journal:  Plast Surg (Oakv)        ISSN: 2292-5503            Impact factor:   0.947


  16 in total

Review 1.  Economic Notes: opportunity cost.

Authors:  S Palmer; J Raftery
Journal:  BMJ       Date:  1999-06-05

2.  What is value in health care?

Authors:  Michael E Porter
Journal:  N Engl J Med       Date:  2010-12-08       Impact factor: 91.245

3.  Treatment of paediatric burns with a nanocrystalline silver dressing compared with standard wound care in a burns unit: a cost analysis.

Authors:  S G Cox; L Cullingworth; H Rode
Journal:  S Afr Med J       Date:  2011-09-27

4.  Burn care costing: the Welsh experience.

Authors:  Sarah J Hemington-Gorse; Tom S Potokar; Peter J Drew; William A Dickson
Journal:  Burns       Date:  2008-10-31       Impact factor: 2.744

5.  A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits.

Authors:  J Fong; F Wood; B Fowler
Journal:  Burns       Date:  2005-02-17       Impact factor: 2.744

6.  Healing at home: Comparing cohorts of children with medium-sized burns treated as outpatients with in-hospital applied Acticoat to those children treated as inpatients with silver sulfadiazine.

Authors:  Daniel A Peters; Cynthia Verchere
Journal:  J Burn Care Res       Date:  2006 Mar-Apr       Impact factor: 1.845

7.  Retrospective comparison of two years in a paediatric burns unit, with and without acticoat as a standard dressing.

Authors:  O Strand; L San Miguel; S Rowan; A Sahlqvist
Journal:  Ann Burns Fire Disasters       Date:  2010-12-31

8.  Ten-year epidemiological study of pediatric burns in Canada.

Authors:  Anneliese Spinks; Jason Wasiak; Heather Cleland; Nicole Beben; Alison K Macpherson
Journal:  J Burn Care Res       Date:  2008 May-Jun       Impact factor: 1.845

9.  A retrospective cohort study of Acticoat versus Silvazine in a paediatric population.

Authors:  Leila Cuttle; Sanjeev Naidu; Julie Mill; Wendy Hoskins; Karina Das; Roy M Kimble
Journal:  Burns       Date:  2007-07-17       Impact factor: 2.744

10.  The true cost of burn.

Authors:  Chris S Ahn; Peter K M Maitz
Journal:  Burns       Date:  2012-07-13       Impact factor: 2.744

View more
  3 in total

1.  Outcomes and Complications of the Mustardé Otoplasty: A "Good-Fast-Cheap" Technique for the Prominent Ear Deformity.

Authors:  Matthew L Boroditsky; Aaron C Van Slyke; Jugpal S Arneja
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-09-24

2.  Through-and-Through Dissection of the Soft Palate for Pharyngeal Flap Inset: A "Good-Fast-Cheap" Technique for Any Etiology of Velopharyngeal Incompetence.

Authors:  Michael Carr; Michaela Skarlicki; Sheryl Palm; Marija Bucevska; Jeffrey Bone; Arun K Gosain; Jugpal S Arneja
Journal:  Cleft Palate Craniofac J       Date:  2021-06-17

Review 3.  Topical antimicrobial agents for pediatric burns.

Authors:  Robert Cartotto
Journal:  Burns Trauma       Date:  2017-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.